Moderna’s cancer-vaccine breakthrough drives broad biopharma stock rally
The biopharmaceutical sector has struggled with a prolonged downturn in recent years but has been on an upswing of late.
This is a summary aggregated from MarketWatch. Read the complete article on the original site:
Read full article at MarketWatch
